GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS

The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RICHTER, YAEL, FARKASH, ORLY, SHULMAN, AVIDOR, BEN DROR, GAI, PELLED, DORI, PLATT, DORIT, ZUABI, RASSAN, BAR-ON, ZOHAR
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RICHTER, YAEL
FARKASH, ORLY
SHULMAN, AVIDOR
BEN DROR, GAI
PELLED, DORI
PLATT, DORIT
ZUABI, RASSAN
BAR-ON, ZOHAR
description The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4. La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2847644C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2847644C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2847644C3</originalsourceid><addsrcrecordid>eNrjZLB394l0dg3yD_DwDwZiH88AT5dgBTf_IIUQD1cFT9-AIP8wV19XvxAFfzcFZ393P88QzzBXBbdQP-cQT3-_YB4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu_saGRhYm5mYuJsTFgFACW1KiE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><source>esp@cenet</source><creator>RICHTER, YAEL ; FARKASH, ORLY ; SHULMAN, AVIDOR ; BEN DROR, GAI ; PELLED, DORI ; PLATT, DORIT ; ZUABI, RASSAN ; BAR-ON, ZOHAR</creator><creatorcontrib>RICHTER, YAEL ; FARKASH, ORLY ; SHULMAN, AVIDOR ; BEN DROR, GAI ; PELLED, DORI ; PLATT, DORIT ; ZUABI, RASSAN ; BAR-ON, ZOHAR</creatorcontrib><description>The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4. La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160809&amp;DB=EPODOC&amp;CC=CA&amp;NR=2847644C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160809&amp;DB=EPODOC&amp;CC=CA&amp;NR=2847644C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RICHTER, YAEL</creatorcontrib><creatorcontrib>FARKASH, ORLY</creatorcontrib><creatorcontrib>SHULMAN, AVIDOR</creatorcontrib><creatorcontrib>BEN DROR, GAI</creatorcontrib><creatorcontrib>PELLED, DORI</creatorcontrib><creatorcontrib>PLATT, DORIT</creatorcontrib><creatorcontrib>ZUABI, RASSAN</creatorcontrib><creatorcontrib>BAR-ON, ZOHAR</creatorcontrib><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><description>The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4. La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB394l0dg3yD_DwDwZiH88AT5dgBTf_IIUQD1cFT9-AIP8wV19XvxAFfzcFZ393P88QzzBXBbdQP-cQT3-_YB4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu_saGRhYm5mYuJsTFgFACW1KiE</recordid><startdate>20160809</startdate><enddate>20160809</enddate><creator>RICHTER, YAEL</creator><creator>FARKASH, ORLY</creator><creator>SHULMAN, AVIDOR</creator><creator>BEN DROR, GAI</creator><creator>PELLED, DORI</creator><creator>PLATT, DORIT</creator><creator>ZUABI, RASSAN</creator><creator>BAR-ON, ZOHAR</creator><scope>EVB</scope></search><sort><creationdate>20160809</creationdate><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><author>RICHTER, YAEL ; FARKASH, ORLY ; SHULMAN, AVIDOR ; BEN DROR, GAI ; PELLED, DORI ; PLATT, DORIT ; ZUABI, RASSAN ; BAR-ON, ZOHAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2847644C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RICHTER, YAEL</creatorcontrib><creatorcontrib>FARKASH, ORLY</creatorcontrib><creatorcontrib>SHULMAN, AVIDOR</creatorcontrib><creatorcontrib>BEN DROR, GAI</creatorcontrib><creatorcontrib>PELLED, DORI</creatorcontrib><creatorcontrib>PLATT, DORIT</creatorcontrib><creatorcontrib>ZUABI, RASSAN</creatorcontrib><creatorcontrib>BAR-ON, ZOHAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RICHTER, YAEL</au><au>FARKASH, ORLY</au><au>SHULMAN, AVIDOR</au><au>BEN DROR, GAI</au><au>PELLED, DORI</au><au>PLATT, DORIT</au><au>ZUABI, RASSAN</au><au>BAR-ON, ZOHAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><date>2016-08-09</date><risdate>2016</risdate><abstract>The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4. La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2847644C
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A33%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RICHTER,%20YAEL&rft.date=2016-08-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2847644C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true